Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate dose-finding study for tracheal intubation induction in emergency patients
ChiCTR2400093402Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in respiratory failure (4 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Incidence of hypotension within 10 minutes after intubation. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
respiratory failure
Beyond the preview
Go deeper on ChiCTR2400093402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093402.